Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R&E tax credit bill

Executive Summary

Like the Bush Administration's recent budget proposal for FY 1990, Sen. Danforth's (R-Mo.) Research & Experimentation bill would make permanent the 20% research and experimentation and basic research tax credits which are scheduled to expire at the end of 1989. Introduced March 15, S 570 also would make changes in the structure of the credit to increase its incentive effect on R&E spending and would extend credit benefits to startup firms to encourage "all taxpayers" to increase R&E spending, according to Danforth. Bill was referred to the Senate Finance Committee; no action scheduled to date.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel